Omega-3-acid Ethyl Esters (Lovaza) For Severe Hypertriglyceridemia
Article Details
- CitationCopy to clipboard
Koski R
Omega-3-acid Ethyl Esters (Lovaza) For Severe Hypertriglyceridemia
Pharmacy and Therapeutics. 2008 May;33(5):271-303.
- PubMed ID
- Not Available
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drugs
- Drug Interactions
Drugs Interaction Integrate drug-drug
interactions in your softwareAbciximabOmega-3-acid ethyl esters The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Abciximab. AcenocoumarolOmega-3-acid ethyl esters The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Acenocoumarol. Acetylsalicylic acidOmega-3-acid ethyl esters The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Acetylsalicylic acid. AlteplaseOmega-3-acid ethyl esters The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Alteplase. AnagrelideOmega-3-acid ethyl esters The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Anagrelide.